CLARITY TIMI

Related by string. * clarity . Clarity : CA Clarity PPM . ACH Clarity . FCX Clarity hydrogen . Clarity FSR . Honda FCX Clarity . FCX Clarity fuel . Altec Lansing Clarity Plantronics . Clarity Matrix / TIMING IS . timid . Timid . Timis . Timi : ENGAGE AF TIMI . Myocardial Infarction TIMI . Filippo Timi . MERLIN TIMI . TRITON TIMI . Timi Gustafson RD . PCI ExTRACT TIMI . indecisive timid * *

Related by context. Frequent words. (Click for all words.) 68 Acute Myocardial Infarction 66 Pivotal Phase III 66 Multicenter 66 Randomized controlled 65 placebo controlled clinical 64 Phase Ib clinical 64 Gynecologic Oncology Group 64 TRITON TIMI 64 randomized Phase III 64 Diabetic Macular Edema 64 metastatic castration resistant 63 prospective multicenter 63 Pulmonary Arterial Hypertension 63 Thrombolysis 63 Percutaneous Coronary Intervention 63 Pravastatin 62 J Am Coll 62 phase IIb clinical 62 Meta Analysis 62 Pivotal Trial 62 PREZISTA r 62 Gemzar ® 62 multicenter clinical 62 Antihypertensive 62 Pivotal Phase 62 metastatic hormone refractory 62 HALTS 61 Enoxaparin 61 Chronic Heart Failure 61 relapsing multiple sclerosis 61 Phase III Clinical Trial 61 ACRIN 61 Phase III Trial 61 Rosuvastatin 61 Chronic Hepatitis C 61 Randomized Controlled Trial 61 Clinical Trial Results 61 Arch Intern Med 61 Telmisartan 61 multicenter Phase 61 relapsed refractory multiple myeloma 60 Phase III randomized 60 Postmenopausal Women 60 Well Tolerated 60 multicenter randomized 60 KRN# 60 SPIRIT IV 60 placebo controlled Phase 60 prospective randomized controlled 60 neoadjuvant 60 Solid Tumors 60 Arch Neurol 60 Amrubicin 60 Phase 1b clinical 60 J Am Acad 60 Myocardial Infarction 60 SWOG 60 Preclinical Data 60 patients undergoing percutaneous 60 Heart Failure Patients 60 Metastatic Colorectal Cancer 60 active comparator 60 phase IIa 60 Engerix B 60 subanalysis 59 TARGIT 59 RADIANT 59 J Clin Oncol 59 REVLIMID lenalidomide 59 RRMS patients 59 Patients Treated 59 pertuzumab 59 bendamustine 59 ZD# [001] 59 #:#-# [031] 59 prospective observational 59 Completes Enrollment 59 Metastatic Melanoma 59 ALLHAT 59 Pioglitazone 59 Pirfenidone 59 multicentre 59 irbesartan 59 randomized controlled clinical 59 Targeted Therapy 59 Natalizumab 59 Diabetic Patients 59 nab paclitaxel 59 lipid lowering drugs 59 goserelin 59 mycophenolate mofetil 58 placebo controlled clinical trials 58 Gastrointestinal Cancers Symposium 58 Acute Coronary Syndrome 58 Monotherapy 58 J Clin Endocrinol Metab 58 bevacizumab Avastin 58 SABCS 58 Benign Prostatic Hyperplasia 58 FREEDOMS 58 Radiation Therapy Oncology

Back to home page